|
|
Mini-Review |
| The biological basis for the attenuation of mucositis: the example of interleukin-11 |
831 |
| S Sonis,
L Edwards & C Lucey
|
|
Abstract
Full Article (PDF)
|
|
Open Forum |
| Guidelines for the characterization and publication of human malignant hematopoietic cell lines |
835 |
| HG Drexler & Y Matsuo
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts |
| Therapy |
| Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia |
843 |
| E Archimbaud,
U Jehn,
X Thomas,
F De Cataldo,
G Fillet,
A Belhabri,
P-Y Peaud,
C Martin,
S Amadori & R Willemze
|
|
Abstract
Full Article (PDF)
|
|
| Treatment of newly diagnosed AML, RAEB-t or RAEB with lisofylline or placebo in addition to chemotherapy |
850 |
| EH Estey,
PF Thall,
P Reed,
H Kantarjian,
M Beran,
S Pierce & MJ Keating
|
|
Abstract
Full Article (PDF)
|
|
| Perspectives in Therapy |
| Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth |
855 |
| V Roginskaya,
S Zuo,
E Caudell,
G Nambudiri,
AJ Kraker & SJ Corey
|
|
Abstract
Full Article (PDF)
|
|
| APL |
| Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia |
862 |
| M-J Mozziconacci,
C Liberatore,
F Grignani,
D Sainty,
PG Pelicci,
F Birg & M Lafage-Pochitaloff
|
|
Abstract
Full Article (PDF)
|
|
| ALL and Cytogenetics |
| Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications |
869 |
| BS Dabaja,
S Faderl,
D Thomas,
J Cortes,
S O’Brien,
F Nasr,
S Pierce,
K Hayes,
A Glassman,
M Keating & HM Kantarjian
|
|
Abstract
Full Article (PDF)
|
|
| Molecular Cytogenetics |
| B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene |
873 |
| D Lens,
LJA Coignet,
V Brito-Babapulle,
CSP Lima,
E Matutes,
MJS Dyer & D Catovsky
|
|
Abstract
Full Article (PDF)
|
|
| Tumor Supressor Genes and Methylation |
| Cancer-specific region of hypermethylation identified within the HIC1 putative tumour suppressor gene in acute myeloid leukaemia |
877 |
| JR Melki,
PC Vincent & SJ Clark
|
|
Abstract
Full Article (PDF)
|
|
| p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation |
884 |
| M Nakamura,
K Sugita,
T Inukai,
K Goi,
K Iijima,
T Tezuka,
S Kojika,
K Shiraishi,
N Miyamoto,
N Karakida,
K Kagami,
T O-Koyama,
T Mori & S Nakazawa
|
|
Abstract
Full Article (PDF)
|
|
| Gene Expression in MDS and AML |
| WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia |
891 |
| P Patmasiriwat,
G Fraizer,
H Kantarjian & GF Saunders
|
|
Abstract
Full Article (PDF)
|
|
| Apoptosis |
| Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds |
901 |
| L Tentori,
M Turriziani,
D Franco,
A Serafino,
L Levati,
R Roy,
E Bonmassar & G Graziani
|
|
Abstract
Full Article (PDF)
|
|
| Sensitivity and Resistance to Therapy |
| Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells |
910 |
| KB Fryxell,
SB McGee,
DK Simoneaux,
CL Willman & MM Cornwell
|
|
Abstract
Full Article (PDF)
|
|
| Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine |
918 |
| E Van Den Neste,
F Bontemps,
A Delacauw,
S Cardoen,
I Louviaux,
JM Scheiff,
E Gillis,
P Leveugle,
V Deneys,
A Ferrant & G Van den Berghe
|
|
Abstract
Full Article (PDF)
|
|
| Growth Factors, Cytokines and Cell Signalling |
| Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1 |
926 |
| D Metcalf,
WS Alexander,
AG Elefanty,
NA Nicola,
DJ Hilton,
R Starr,
S Mifsud & L Di Rago
|
|
Abstract
Full Article (PDF)
|
|
| Megakaryocytic Differentiation |
| Megakaryocytic differentiation of human progenitor cells is negatively influenced by direct contact with stroma |
935 |
| S Zweegman,
MA Veenhof,
N Debili,
GJ Schuurhuis,
PC Huijgens & AM Dräger
|
|
Abstract
Full Article (PDF)
|
|
| Stem Cell Harvests in CML |
| Analysis of CD34 populations in mobilised peripheral blood stem cell harvests and in bone marrow by fluorescent in situ hybridisation for the bcr/abl gene fusion in patients with chronic granulocytic leukaemia |
944 |
| JAE Irving,
A Lennard,
N Storey,
J Conn,
J Dunn,
K Oliver,
SJ Proctor & AM Dickinson
|
|
Abstract
Full Article (PDF)
|
|
| Lymphoma |
| Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients |
950 |
| R Bouabdallah,
A-M Stoppa,
J-F Rossi,
G Lepeu,
D Coso,
L Xerri,
P Ladaique,
C Chabannon,
D Blaise,
V-J Bardou,
C Alzieu,
J-A Gastaut & D Maraninchi
|
|
Abstract
Full Article (PDF)
|
|
| Biotechnical Methods Section (BTS) |
| Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a ‘real time’ quantitative RT-PCR assay |
957 |
| C Preudhomme,
F Révillion,
A Merlat,
L Hornez,
C Roumier,
N Duflos-Grardel,
JP Jouet,
A Cosson,
JP Peyrat & P Fenaux
|
|
Abstract
Full Article (PDF)
|
|
| Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis |
965 |
| AW Langerak,
ILM Wolvers-Tettero & JJM van Dongen
|
|
Abstract
Full Article (PDF)
|
|
Brief Communication |
| Molecular characterization of a complex chromosomal translocation breakpoint t(10;14) including the HOX11 oncogene locus |
975 |
| PD Salvati,
PM Watt,
WR Thomas & UR Kees
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| Low-dose cytarabine (LD-AraC) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for myelodysplastic syndromes (MDS) |
980 |
| A Kikuchi,
H Ohashi,
R Hanada & K Yamamoto
|
|
Full Article (PDF)
|
|
| Are we ready to curtail testing TEL/AML1 fusion? |
981 |
O Hru ák,
J Trka,
J Zuna,
J Bart  ková,
J Starý
for Pediatric Hematology Working Group in the Czech Republic
|
|
Full Article (PDF)
|
|
| Reply |
| Reply: Immunophenotypic prediction of TEL-AML1 rearrangement in childhood ALL |
983 |
| MJ Borowitz,
J Rubnitz,
M Nash,
DJ Pullen,
B Camitta
for the Pediatric Oncology Group
|
|
Full Article (PDF)
|
|
